论文部分内容阅读
目的探讨尤瑞克林治疗急性脑梗死的临床疗效和不良反应。方法 102例急性脑梗死患者随机分为2组,尤瑞克林治疗组51例,常规治疗组51例。通过神经功能缺损评分判断疗效,观察治疗后2组神经功能改善情况。结果尤瑞克林治疗组有效率为86.28%,常规治疗组有效率为66.67%,尤瑞克林治疗组治疗有效率显著高于对照组,2组比较差异有统计学意义(P﹤0.05)。2组均未发现严重的不良反应。结论尤瑞克林治疗急性脑梗死安全、有效。
Objective To investigate the clinical efficacy and side effects of urelin in the treatment of acute cerebral infarction. Methods A total of 102 patients with acute cerebral infarction were randomly divided into two groups: 51 patients in the urethrin-treated group and 51 in the conventional treatment group. The curative effect was judged by neurological deficit score, and the improvement of neurological function was observed in 2 groups after treatment. Results Erectile function in the treatment group was 86.28%, while in the conventional treatment group, the effective rate was 66.67%. The treatment efficiency in the uracrillin group was significantly higher than that in the control group. The difference was statistically significant (P <0.05) . No serious adverse reaction was found in both groups. Conclusion Urelin is safe and effective in the treatment of acute cerebral infarction.